TITLE:
Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder

CONDITION:
Depressive Disorder

INTERVENTION:
Duloxetine Hydrochloride

SUMMARY:

      The purpose of this study is to determine if duloxetine is effective when compared to
      placebo in preventing recurrence of major depressive disorder in patients who have responded
      to open-label duloxetine treatment.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Signed the informed consent

          -  Meet criteria for major depressive disorder without psychotic features.

          -  Have a level of understanding sufficient to provide informed consent and to
             communicate with the investigator and site personnel.

          -  Have had at least one other major depressive episode prior to the one being
             experienced at study entry.

          -  You are reliable and agree to keep all appointments for clinic visits, tests and
             procedures required by the protocol.

        Exclusion Criteria:

          -  You have had treatment with a drug within the last 30 days that has not received
             regulatory approval at the time of study entry.

          -  Any women who are pregnant or breast feeding.

          -  If you have any serious medical illnesses other than major depressive disorder.

          -  If you have previously participated in a clinical trial for duloxetine.

          -  Any previous or current diagnosis of bipolar, schizophrenia, or other psychotic
             disorders.
      
